# Embryonic Dopamine Cell Implants for Parkinson's Disease

> **NCT00038116** · PHASE3 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 40 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **PROCEDURE:** embryonic dopamine cell implant surgery
- **PROCEDURE:** placebo

## Key facts

- **NCT ID:** NCT00038116
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-05
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00038116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00038116, "Embryonic Dopamine Cell Implants for Parkinson's Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00038116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*